secwatch.observer — SEC 8-K summary
======================================

Issuer:     Moleculin Biotech, Inc. (MBRX)
CIK:        0001659617
Form:       8-K
Filed at:   2023-08-21T23:59:59+00:00
Accession:  0001437749-23-024329
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Moleculin Biotech amends bylaws; reduces stockholder quorum from majority to one-third
--------------------------------------------------------------------------------

- Board adopted Third Amended and Restated Bylaws effective August 18, 2023.
- Quorum for stockholder meetings reduced from majority to one-third of voting power.
- Directors may be removed with or without cause by majority vote.
- Updated procedures for stockholder proposals and remote meeting capability.
- Conforming changes and updates consistent with Delaware law.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1659617/000143774923024329/0001437749-23-024329-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1659617/000143774923024329/mbrx20230821_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-024329

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer